Comerica Bank Supernus Pharmaceuticals, Inc. Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Comerica Bank holds 21,963 shares of SUPN stock, worth $795,499. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,963

Previous 22,618 2.9%

Holding current value

$795,499

Previous $605,000 13.06%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$25.77 - $35.16 $16,879 - $23,029	-655 Reduced 2.9%	21,963 $684,000
Q2 2024 Aug 15, 2024	SELL	$25.99 - $33.85 $68,145 - $88,754	-2,622 Reduced 10.39%	22,618 $605,000
Q1 2024 May 15, 2024	SELL	$27.11 - $35.17 $64,521 - $83,704	-2,380 Reduced 8.62%	25,240 $860,000
Q4 2023 Feb 14, 2024	SELL	$22.72 - $29.68 $90 - $118	-4 Reduced 0.01%	27,620 $799,000
Q3 2023 Nov 21, 2023	BUY	$27.57 - $32.91 $761,593 - $909,105	27,624 New	27,624 $761,000
Q4 2022 Jan 26, 2023	SELL	$31.09 - $37.88 $277,478 - $338,079	-8,925 Reduced 21.53%	32,528 $0
Q3 2022 Oct 28, 2022	SELL	$28.79 - $35.41 $129,123 - $158,813	-4,485 Reduced 9.76%	41,453 $1.41 Million
Q2 2022 Aug 02, 2022	SELL	$25.33 - $34.25 $886 - $1,198	-35 Reduced 0.08%	45,938 $1.38 Million
Q1 2022 Apr 27, 2022	SELL	$28.51 - $32.9 $4,419 - $5,099	-155 Reduced 0.34%	45,973 $1.49 Million
Q4 2021 Feb 18, 2022	SELL	$26.37 - $34.22 $66,663 - $86,508	-2,528 Reduced 5.2%	46,128 $1.35 Million
Q3 2021 Nov 22, 2021	SELL	$23.54 - $31.39 $21,468 - $28,627	-912 Reduced 1.84%	48,656 $1.3 Million
Q2 2021 Aug 26, 2021	SELL	$26.72 - $33.19 $104,154 - $129,374	-3,898 Reduced 7.29%	49,568 $1.53 Million
Q1 2021 Apr 28, 2021	SELL	$24.15 - $31.45 $45,643 - $59,440	-1,890 Reduced 3.41%	53,466 $1.4 Million
Q4 2020 Jan 28, 2021	BUY	$17.7 - $25.81 $5,239 - $7,639	296 Added 0.54%	55,356 $1.39 Million
Q3 2020 Oct 30, 2020	SELL	$20.2 - $25.05 $3,333 - $4,133	-165 Reduced 0.3%	55,060 $1.15 Million
Q2 2020 Jul 31, 2020	BUY	$17.09 - $24.89 $71,419 - $104,015	4,179 Added 8.19%	55,225 $1.31 Million
Q1 2020 May 01, 2020	BUY	$14.45 - $24.69 $26,833 - $45,849	1,857 Added 3.78%	51,046 $918,000
Q4 2019 Feb 07, 2020	SELL	$19.93 - $29.13 $777 - $1,136	-39 Reduced 0.08%	49,189 $1.17 Million
Q3 2019 Oct 31, 2019	SELL	$25.47 - $33.37 $6,545 - $8,576	-257 Reduced 0.52%	49,228 $1.35 Million
Q2 2019 Aug 02, 2019	SELL	$29.96 - $38.87 $79,933 - $103,705	-2,668 Reduced 5.12%	49,485 $0
Q1 2019 May 02, 2019	BUY	$32.77 - $41.99 $47,057 - $60,297	1,436 Added 2.83%	52,153 $0
Q4 2018 Feb 06, 2019	BUY	$30.84 - $49.51 $5,211 - $8,367	169 Added 0.33%	50,717 $1.86 Million
Q3 2018 Nov 01, 2018	SELL	$42.7 - $56.55 $174,301 - $230,837	-4,082 Reduced 7.47%	50,548 $2.39 Million
Q2 2018 Aug 01, 2018	BUY	$44.1 - $59.85 $26,592 - $36,089	603 Added 1.12%	54,630 $2.93 Million
Q1 2018 May 01, 2018	BUY	$37.15 - $46.9 $46,846 - $59,140	1,261 Added 2.39%	54,027 $2.64 Million
Q4 2017 Feb 02, 2018	SELL	$36.4 - $42.6 $34,652 - $40,555	-952 Reduced 1.77%	52,766 $2.28 Million
Q3 2017 Nov 06, 2017	BUY	$36.75 - $49.65 $1.97 Million - $2.67 Million	53,718	53,718 $2.2 Million

Others Institutions Holding SUPN

# of Institutions

282

Shares Held

60.9M

Call Options Held

27.7K

Put Options Held

11.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.94B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account